Postoperative Pain Control Following Vitreoretinal Surgery

NCT01995045 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2017-03-21

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate if patients receiving a steroid (triamcinolone acetonide) combined with local anesthesia and antibiotic following retina surgery have better postoperative pain control those receiving local anesthesia and antibiotic alone.

Conditions

  • Retinal Detachment
  • Proliferative Vitreoretinopathy
  • Retinoschisis

Interventions

DRUG

Triamcinolone

Retrobulbar anesthesia

DRUG

Bupivicaine Hydrochloride

Retrobulbar anesthesia

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Timothy W Olsen, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01995045 on ClinicalTrials.gov